Wallace DS, Rowland C, Hill BT, Baran AM, et al. Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma. Leuk Lymphoma 2023 Jun 21:1-4. doi: 10.1080/10428194.2023.2223743.
PMID: 37341984